NEUROCRINE BIOSCIENCES INC Increase (Decrease) in Inventories
NEUROCRINE BIOSCIENCES INC (NBIX) reported Increase (Decrease) in Inventories of $2.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-31
- NEUROCRINE BIOSCIENCES INC increase (decrease) in inventories for the quarter ending 2026-06-30 was $6.50M.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in inventories for the quarter ending 2026-03-31 was -$4.30M, a 352.94% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in inventories for the quarter ending 2025-12-31 was $3.40M, a 70.69% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in inventories for the quarter ending 2025-09-30 was $12.30M, a 272.73% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in inventories for fiscal 2025 was $15.30M, a 19.90% decline from fiscal 2024.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in inventories for fiscal 2024 was $19.10M.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in inventories for fiscal 2023 was -$5.40M, a 307.69% decline from fiscal 2022.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in inventories for fiscal 2022 was $2.60M, a 4.00% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $2.20M 10-Q · filed 2026-07-31 | $5.60M derived: sum of 3 quarters · filed 2026-07-31 | $17.90M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2026-03-31 | -$4.30M 10-Q · filed 2026-05-05 | -$900.00K derived: sum of 2 quarters · filed 2026-05-05 | $11.40M derived: sum of 3 quarters · filed 2026-05-05 | $9.30M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $15.70M derived: sum of 2 quarters · filed 2026-02-11 | $13.60M derived: sum of 3 quarters · filed 2026-07-31 | $15.30M 10-K · filed 2026-02-11 | ||||
| 2025-09-30 | $12.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $10.20M derived: sum of 2 quarters · filed 2026-07-31 | $11.90M 10-Q · filed 2025-10-28 | $23.50M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | -$400.00K 10-Q · filed 2026-07-31 | $11.20M derived: sum of 3 quarters · filed 2026-07-31 | $14.50M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-03-31 | $1.70M 10-Q · filed 2026-05-05 | $13.30M derived: sum of 2 quarters · filed 2026-05-05 | $16.60M derived: sum of 3 quarters · filed 2026-05-05 | $21.90M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $11.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $14.90M derived: sum of 2 quarters · filed 2026-02-11 | $20.20M derived: sum of 3 quarters · filed 2026-02-11 | $19.10M 10-K · filed 2026-02-11 | ||||
| 2024-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $8.60M derived: sum of 2 quarters · filed 2025-10-28 | $7.50M 10-Q · filed 2025-10-28 | $8.40M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | $5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $4.20M 10-Q · filed 2025-07-30 | $5.10M derived: sum of 3 quarters · filed 2026-02-11 | $2.20M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | -$1.10M 10-Q · filed 2025-05-05 | -$200.00K derived: sum of 2 quarters · filed 2026-02-11 | -$3.10M derived: sum of 3 quarters · filed 2026-02-11 | -$4.70M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$2.00M derived: sum of 2 quarters · filed 2026-02-11 | -$3.60M derived: sum of 3 quarters · filed 2026-02-11 | -$5.40M 10-K · filed 2026-02-11 | ||||
| 2023-09-30 | -$2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$4.50M derived: sum of 2 quarters · filed 2024-10-30 | -$6.30M 10-Q · filed 2024-10-30 | -$10.20M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-06-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$3.40M 10-Q · filed 2024-08-01 | -$7.30M derived: sum of 3 quarters · filed 2025-02-10 | $400.00K derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-03-31 | -$1.80M 10-Q · filed 2024-05-01 | -$5.70M derived: sum of 2 quarters · filed 2025-02-10 | $2.00M derived: sum of 3 quarters · filed 2025-02-10 | $2.30M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2022-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $3.80M derived: sum of 2 quarters · filed 2025-02-10 | $4.10M derived: sum of 3 quarters · filed 2025-02-10 | $2.60M 10-K · filed 2025-02-10 | ||||
| 2022-09-30 | $7.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $8.00M derived: sum of 2 quarters · filed 2023-10-31 | $6.50M 10-Q · filed 2023-10-31 | $11.50M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$1.20M 10-Q · filed 2023-08-01 | $3.80M derived: sum of 3 quarters · filed 2024-02-09 | $1.00M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-03-31 | -$1.50M 10-Q · filed 2023-05-03 | $3.50M derived: sum of 2 quarters · filed 2024-02-09 | $700.00K derived: sum of 3 quarters · filed 2024-02-09 | -$1.10M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2021-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $2.20M derived: sum of 2 quarters · filed 2024-02-09 | $400.00K derived: sum of 3 quarters · filed 2024-02-09 | $2.50M 10-K · filed 2024-02-09 | ||||
| 2021-09-30 | -$2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$4.60M derived: sum of 2 quarters · filed 2022-11-01 | -$2.50M 10-Q · filed 2022-11-01 | $4.80M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $300.00K 10-Q · filed 2022-08-04 | $7.60M derived: sum of 3 quarters · filed 2023-02-09 | $6.30M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | $2.10M 10-Q · filed 2022-05-04 | $9.40M derived: sum of 2 quarters · filed 2023-02-09 | $8.10M derived: sum of 3 quarters · filed 2023-02-09 | $8.90M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $6.00M derived: sum of 2 quarters · filed 2023-02-09 | $6.80M derived: sum of 3 quarters · filed 2023-02-09 | $10.70M 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | -$500.00K derived: sum of 2 quarters · filed 2021-11-01 | $3.40M 10-Q · filed 2021-11-01 | $9.90M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $4.70M 10-Q · filed 2021-08-03 | $11.20M derived: sum of 3 quarters · filed 2022-02-11 | $9.90M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-03-31 | $3.90M 10-Q · filed 2021-05-05 | $10.40M derived: sum of 2 quarters · filed 2022-02-11 | $9.10M derived: sum of 3 quarters · filed 2022-02-11 | $8.50M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2019-12-31 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $5.20M derived: sum of 2 quarters · filed 2022-02-11 | $4.60M derived: sum of 3 quarters · filed 2022-02-11 | $6.40M 10-K · filed 2022-02-11 | $6.42M 10-K · filed 2020-02-07 | |||
| 2019-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.90M derived: sum of 2 quarters · filed 2020-11-09 | -$100.00K 10-Q · filed 2020-11-09 | -$66.00K 10-Q · filed 2019-11-04 | -$507.00K derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2019-06-30 | -$600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $1.20M 10-Q · filed 2020-08-03 | $1.15M 10-Q · filed 2019-07-29 | $793.00K derived: sum of 3 quarters · filed 2021-02-05 | $1.43M derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2019-03-31 | $1.80M 10-Q · filed 2020-05-06 | $1.75M 10-Q · filed 2019-04-29 | $1.39M derived: sum of 2 quarters · filed 2021-02-05 | $2.03M derived: sum of 3 quarters · filed 2021-02-05 | $4.99M derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2018-12-31 | -$407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-05 | $229.00K derived: sum of 2 quarters · filed 2021-02-05 | $3.19M derived: sum of 3 quarters · filed 2021-02-05 | $3.50M 10-K · filed 2021-02-05 | $3.52M 10-K · filed 2019-02-08 | |||
| 2018-09-30 | $636.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $3.60M derived: sum of 2 quarters · filed 2019-11-04 | $3.91M 10-Q · filed 2019-11-04 | $4.69M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $3.27M 10-Q · filed 2019-07-29 | $4.05M derived: sum of 3 quarters · filed 2020-02-07 | $4.17M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-03-31 | $309.00K 10-Q · filed 2019-04-29 | $1.09M derived: sum of 2 quarters · filed 2020-02-07 | $1.21M derived: sum of 3 quarters · filed 2020-02-07 | |||||
| 2017-12-31 | $782.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $896.00K derived: sum of 2 quarters · filed 2020-02-07 | $1.02M 10-K · filed 2020-02-07 | |||||
| 2017-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $242.00K 10-Q · filed 2018-11-05 | ||||||
| 2017-06-30 | $128.00K 10-Q · filed 2018-07-31 | |||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-08 | $0.00 derived: sum of 2 quarters · filed 2019-02-08 | $0.00 10-K · filed 2019-02-08 | |||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 10-Q · filed 2017-11-01 | ||||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | |||||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |